- Home
- DVAX vs XNCR Comparison
DVAX vs XNCR Comparison
Compare DVAX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- XNCR
- Stock Information
- Founded
- DVAX 1996
- XNCR 1997
- Country
- DVAX United States
- XNCR United States
- Employees
- DVAX N/A
- XNCR N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- DVAX Health Care
- XNCR Health Care
- Exchange
- DVAX Nasdaq
- XNCR Nasdaq
- Market Cap
- DVAX N/A
- XNCR 579.3M
- IPO Year
- DVAX 2004
- XNCR 2013
- Fundamental
- Price
- DVAX $10.27
- XNCR $8.42
- Analyst Decision
- DVAX Buy
- XNCR Buy
- Analyst Count
- DVAX 4
- XNCR 7
- Target Price
- DVAX $26.25
- XNCR $27.50
- AVG Volume (30 Days)
- DVAX 1.8M
- XNCR 763.4K
- Earning Date
- DVAX 08-05-2025
- XNCR 08-04-2025
- Dividend Yield
- DVAX N/A
- XNCR N/A
- EPS Growth
- DVAX N/A
- XNCR N/A
- EPS
- DVAX N/A
- XNCR N/A
- Revenue
- DVAX $294,620,000.00
- XNCR $127,228,000.00
- Revenue This Year
- DVAX $21.18
- XNCR N/A
- Revenue Next Year
- DVAX $16.83
- XNCR $28.84
- P/E Ratio
- DVAX N/A
- XNCR N/A
- Revenue Growth
- DVAX 24.76
- XNCR N/A
- 52 Week Low
- DVAX $9.22
- XNCR $7.16
- 52 Week High
- DVAX $14.63
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- DVAX 54.20
- XNCR 44.91
- Support Level
- DVAX $9.79
- XNCR $7.65
- Resistance Level
- DVAX $10.38
- XNCR $8.57
- Average True Range (ATR)
- DVAX 0.34
- XNCR 0.50
- MACD
- DVAX 0.04
- XNCR -0.04
- Stochastic Oscillator
- DVAX 60.19
- XNCR 34.35
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.